Yes. Avandia is also classified as a peroxisome proliferator-activated receptor (PPAR) agonist. However, Avandia has had issues with increased risk of heart issues. It has recently been severely restricted in its use in the U.S. and banned in Europe
Lead Counsel independently verifies attorneys by conferring with state bar associations and conducting annual reviews to confirm that an attorney practices in their advertised practice areas and possesses a valid bar license for the appropriate jurisdictions.
Attorneys Rated by Super Lawyers®
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The patented selection process includes independent research, peer nominations, and peer evaluations. The number provided represents the number of attorneys at the firm that have been selected to the Super Lawyers or Rising Stars lists.
Average experience reflects the average number of years that the attorneys at this firm have been licensed to practice law. The experience is based on data from the respective state bar association, where this information is available.